跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 120 条关于
“TGFBR2”
全部
120
临床试验
71
药物
30
机构
0
资讯
19
去年
CRISPR Gene Editing Advances CAR-NK Cell Therapy to Overcome Clinical Bottlenecks
上个月
Genomic Profiling of High-Risk Pediatric Tumors Reveals Actionable Alterations in Nearly One-Quarter of Patients
去年
Comprehensive Review Identifies Key Biomarkers for Predicting Gastric Cancer Immunotherapy Response
11个月前
Incyte Presents Early Clinical Data for Novel Oncology Therapies at ESMO Congress 2025
去年
TGFB2 Gene Methylation Identified as Positive Prognostic Biomarker for Pancreatic Cancer
去年
Swissmedic Grants Temporary Authorization to Lytgobi for FGFR2-Rearranged Cholangiocarcinoma
去年
Dual SHP2 and FGFR2 Inhibition Shows Promise in Treatment-Resistant Gastric Cancer
前天
HLB's Elevar Submits EMA Marketing Application for Lirafugratinib in FGFR2-Driven Cholangiocarcinoma
前天
Elevar Submits EMA Marketing Authorization Application for Lirafugratinib in FGFR2-Fusion Cholangiocarcinoma
去年
HUTCHMED Completes Enrollment for Phase II Registration Trial of Fanregratinib in FGFR2-Fusion Cholangiocarcinoma
第 1 页,共 2 页
上一页
下一页